Partner Nate Lacktman was quoted in a Bloomberg Law article, “Federal Audits of Telehealth to Shape Its Post-Pandemic Future,” about a federal probe into whether the expansion of telehealth services during the pandemic opened the door to fraud and abuse.
Lacktman, chair of the firm’s Telemedicine and Digital Health Industry team, said the rate at which laws and rules for telemedicine have changed during the pandemic has been “incredibly fast.” And health care is already supremely complicated from a regulatory perspective, even before you factor in the 50 different states, he added.
“[T]he result of all this is that there’s a lot of confusion, even among well-intentioned providers,” he said. “I think the audits will shed light on that.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”